Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
Recent advances in prostate cancer awareness have transformed how the disease is detected and treated. New screening tools, including AI-enhanced MRI and urine-based biomarker tests, are catching ...
A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Secondary Cancers After NSCLC: What’s the Risk? Among survivors of non-small cell lung cancer, nearly 8% developed non-lung secondary cancers over about 6 years, and this risk may be driven by genetic ...
Tommy Cannon shares prostate cancer update with fans and urges men to get tested - The comedian also recalled a particularly ...
This is an opinion column. I handed the sheet of paper to my wife. It was filled with words, necessary and important words. I couldn’t see them, though — or, couldn’t see them. “Brief Summary of ...
The Government has issued an important statement on prostate cancer and the potential for a screening programme, starting with high-risk men. Its message responds to an ongoing parliamentary petition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results